drugset / Trial / NCT01814241
Mechanisms of Desensitization During Peanut Oral Immunotherapy
Phase 2
Completed
20 enrolled
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID) · collab
NaSingle-groupOpen-labelOther
Summary
The purpose of this study is to attempt to understand how desensitization works in peanut allergic children who are undergoing oral immunotherapy (OIT) to peanut. We want to identify the early changes in the desensitization process the immune cells undergo to become desensitized to the peanut protein.
Timeline
- Start
- 2013-04
- Primary completion
- 2015-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Peanut Flour | Protein / enzyme biologic | 1450 mg | Oral |